There is considerable confusion about the role of mammograms in breast cancer detection in premenopausal women. The US is the only country in the world making the recommendation that they be done on women under the age of 50. The people standing to profit from doing mammograms in this age group are the mammogram industry, Big Pharma in the sale of chemotherapy, and health care practitioners who treat people for cancer. Too many early cancers are found that do not progress and which do not kill are found and unnecessarily treated (DCIS). Recent data shows that it is necessary to do 1800 mammograms to save a single life. This would lead to far too many biopsies and treatment. The US is the only country in the world making the recommendation that they be done on women under the age of 50. The people standing to profit from doing mammograms in this age group are the mammogram industry, Big Pharma in the sale of chemotherapy, and health care practitioners who treat people for cancer. Too many early cancers are found that do not progress and which do not kill are found and unnecessarily treated (DCIS). Recent data shows that it is necessary to do 1800 mammograms to save a single life. This would lead to far too many biopsies and treatment.
As a woman ages her chances of being diagnosed with a low risk breast tumor increases. Women over 50 years old have too many cancers detected by mammograms that are not dangerous and lead to unnecessary biopsies and treatment with surgery, chemo, and radiation. UCSF researchers used a molecular testing device to determine the extent of malignancy breast cancers without metastases have and then correlated cancers from 20 years ago to the past decade and found that mammography revealed a large number of slow to moderate growth tumors in today's women compared to an era where mammograms were not done so routinely.
Let's face it. Mammograms are far from a perfect test, especially in women under the age of 50, and particularly in women with fibrocystic breasts. The United States Preventive Task Force no longer recommends screening women routinely for breast cancer with mammograms in this age group. There has been a flood of complaining from the American Cancer Society and the mammography industry that this is a mistake, and that many lives are lost to breast cancer as a result.
According to researchers at the University of California Medical Center, and published in the March issue of Internal Medicine, screening for breast cancer every two years is preferrable to yearly screens when doing mammograms. This was based on a study of 900,000 women. It appears that this applies to women from the age of 50-94. Mammograms picked up the same number and size of tumors whether done annually or biennially and whether or not women had dense breasts or were on hormone replacement therapy! However, for women under the age of 40 this was not true.
Less frequent mammograms for wonem at low risk for breast cancer can be a cost effective way of saving lives. Women with no family history of breast cancer, no previous biopsy and breasts that are not dense need far fewer mammograms than women with these risk factors. For women under the age of 50 without these three risk factors, mammograms are not worthwhile. To save one life among women under the age of 50, 8000 women would have to be screened and 17% would experience a false positive cancer scare that would lead to more radiation and a biopsy. Women with dense breasts under age 50 would benefit from a mammogram every three to four years. For older women without these three risk factors, it is cost effective to do mammograms every 3-4 years. For those with denser breasts, every two years is recommended.
One third of cancers detected by mammography may not be life-threatening according to the November of 2012 issue of the New England Journal of Medicine. Over the past 3 decades, an estimated 1.3 million women have been over-diagnosed of breast cancer that has led to treatment for a cancer for which they did not need treatment.
The Canadian Task Force on Preventive Health Care now recommends mammograms every three years, no self breast examinations, and no clinical breast exams. They believe these procedures cause too many needless biopsies, mental anguish, and over treatment. This also leads to massive overtreatment of DCIS (ductal carcinoma in situ) which is only life-threatening in 2% of cases. DCIS can be cautiously followed, but unfortunately is overtreated.

